September 18 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said on Wednesday that local Donev Investments Holding has acquired 500 shares in the company at a weighed average price per share of 6.31 levs ($3.57/3.23 euro).
Donev Investments Holding acquired the shares through deals on the floor of the Bulgarian Stock Exchange on September 16, Sopharma Trading said in a bourse filing.
Donev Investments Holding is controlled by the chairman of Sopharma Trading's board of directors - Ognyan Donev. Donev is also the CEO of Sopharma Trading's majority owner - drug maker Sopharma [BUL:3JR].
At the end of June, Sopharma held a 72.97% stake in Sopharma Trading, while Donev Investments Holding held directly a stake of under 5%.
As at 13:45 CET on Wednesday, Sopharma Trading shares traded 0.79% lower at 6.25 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)